Results 231 to 240 of about 1,126,621 (254)
Some of the next articles are maybe not open access.

AI & COVID-19

Intelligenza Artificiale, 2022
The COVID-19 pandemic has influenced our lives significantly since March 2020, and a number of initiatives have been put forward in order to tackle its effects, including those focused on technological solutions. In this paper, we present one of such initiatives, i.e.
Bacciu D.   +3 more
openaire   +4 more sources

COVID-19 therapeutics

Clinical Microbiology Reviews
SUMMARY Since the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options has been studied and deployed. Healthcare providers have multiple treatment approaches to choose from, but efficacy of those approaches often remains controversial or compromised by viral evolution.
Daniele Focosi   +3 more
openaire   +2 more sources

Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?

Ca-A Cancer Journal for Clinicians, 2021
Pelin Cinar, Daniela A Bota, Emad Elquza
exaly  

Long COVID: major findings, mechanisms and recommendations

Nature Reviews Microbiology, 2023
Hannah Davis   +2 more
exaly  

Therapeutic strategies for COVID-19: progress and lessons learned

Nature Reviews Drug Discovery, 2023
Guangdi Li   +2 more
exaly  

The effects of the COVID-19 pandemic on community respiratory virus activity

Nature Reviews Microbiology, 2022
Eric J Chow   +2 more
exaly  

Hematology and oncology clinical care during the coronavirus disease 2019 pandemic

Ca-A Cancer Journal for Clinicians, 2020
Manish A Shah   +2 more
exaly  

Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study

Lancet, The, 2022
Aranka Viviënne Ballering   +1 more
exaly  

Home - About - Disclaimer - Privacy